Treace Medical Concepts Inc当前公司基本面数据相对稳定,增长潜力较大。当前估值合理,在医疗设备与耗材行业排名124/207位。机构持股占比非常高,近一月多位分析师给出公司评级为持有。最高目标价5.47。中期看,股价处于下降通道。近一个月,市场表现非常差,但基本面评分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。
Treace Medical Concepts Inc评分
相关信息
行业排名
124 / 207
全市场排名
313 / 4563
所属行业
医疗设备与耗材
压力支撑
由于公司未披露,未能获取相关数据
多维评测
本期评分
上期评分
分析师目标
根据
6
位分析师
持有
评级
5.470
目标均价
+109.58%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议
Treace Medical Concepts Inc亮点
亮点风险
Treace Medical Concepts, Inc. is a medical technology company. It is advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty 3D Minimally Invasive Bunion Correction System and the Percuplasty Percutaneous 3D Bunion Correction System. It sells its products to physicians, surgeons, ambulatory surgery centers, hospitals, and stocking distributors.
Treace Medical Concepts, Inc. is a medical technology company. It is advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty 3D Minimally Invasive Bunion Correction System and the Percuplasty Percutaneous 3D Bunion Correction System. It sells its products to physicians, surgeons, ambulatory surgery centers, hospitals, and stocking distributors.
公司代码TMCI
公司Treace Medical Concepts Inc
CEOTreace (John T)
网址https://www.treace.com/
常见问题
Treace Medical Concepts Inc(TMCI)的当前股价是多少?
Treace Medical Concepts Inc(TMCI)的当前股价是 2.420。
Treace Medical Concepts Inc的股票代码是什么?
Treace Medical Concepts Inc的股票代码是TMCI。
Treace Medical Concepts Inc股票的52周最高点是多少?
Treace Medical Concepts Inc股票的52周最高点是10.790。
Treace Medical Concepts Inc股票的52周最低点是多少?
Treace Medical Concepts Inc股票的52周最低点是2.360。
Treace Medical Concepts Inc的市值是多少?
Treace Medical Concepts Inc的市值是154.17M。
Treace Medical Concepts Inc的净利润是多少?
Treace Medical Concepts Inc的净利润为-55.74M。
现在Treace Medical Concepts Inc(TMCI)的股票是买入、持有还是卖出?
根据分析师评级,Treace Medical Concepts Inc(TMCI)的总体评级为持有,目标价格为5.470。
Treace Medical Concepts Inc(TMCI)股票的每股收益(EPS TTM)是多少
Treace Medical Concepts Inc(TMCI)股票的每股收益(EPS TTM)是-0.794。